Feb 9, 2024: Neodocs, the in-home wellness tracker startup has secured $2 million to fuel its growth in the international geographies like Europe, Australia, the Middle East, and the Americas. The startup also plans to introduce instant finger-prick blood tests, enabling users to receive results directly on their phones by capturing a picture.
The firm has developed kits for kidney and UTI tests, detecting early signs of kidney disease and urinary tract infections quickly using any smartphone.
“Healthcare today remains reactive and episodic. Affordable and real-time diagnostics will be critical to accelerate the transition to preventive proactive care. We believe Neodocs’ pioneering solution can significantly expand access across income segments and geographies, enrich patient health records and reduce cost of care to improve health outcomes,” Aditya Misra, Director, Omidyar Network India said.
Founded by Nikunj Malpani, Anurag Meena and Pratik Lodha, the Neodocs has already sold 200,000 urine-based tests for Kidney and UTI care kits and has been adopted by more than 4,000 doctors across India.
Neodocs reveals a pipeline of new in-home wellness trackers
Furthermore, the startup collaborates with major pharmaceutical firms such as Cipla, Eris, Sun Pharma, AstraZeneca, Bayer, and RPG Life Sciences. It also partners with the Government of Maharashtra (specifically in Nashik) and the Government of Rajasthan (particularly in Ladnu) to digitise testing services in remote regions.
The startup product pipeline includes the Vitamin D Rapid Test Cassette for quick assessment of Vitamin D levels, the HbA1c Self-Test Kit enabling convenient monitoring of blood sugar levels at home, and Ferritin Testing for accurate assessment of iron levels in the body. Additionally, we offer Rapid Testing for Thyroid Stimulating Hormone (TSH), providing swift and precise evaluation of thyroid function
Neodocs seed funding round was led by Omidyar Network India alongside Y-Combinator, 9Unicorns, Gemba Capital, Titan Capital, Kunal Shah and others.